Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Core Diagnostics to Offer Precipio's Liquid Biopsy Tests in India

Core Diagnostics to Offer Precipio's Liquid Biopsy Tests in India

Mar 26, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Precipio said today that India's Core Diagnostics will now offer liquid biopsy testing using Precipio's ICE COLD-PCR technology to major hospital networks throughout India and the surrounding region.

Financial terms of the laboratory services agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
12
Featured Webinar

Demystifying COVID-19 Antibody Testing

Sponsored by
Truvian

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. 

Aug
18
Featured Webinar

COVID-19 Wastewater-Based Epidemiology: Methods and Insights for SARS-CoV-2 Community Surveillance

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Molecular Diagnostics

  1. Becton Dickinson Fiscal Q3 Revenues Drop 11 Percent

  2. Luminex Responds to FDA Warning Letter While Ramping SARS-CoV-2 Test Manufacturing

    Premium

  3. NHS Will Roll Out COVID-19 Tests From DnaNudge, Oxford Nanopore Across UK

  4. Genedrive, Beckman Coulter Life Sciences Partner on Automated PCR Testing for SARS-CoV-2

  5. Natera Revenues Climb 16 Percent in Q2 Driven by Reproductive Health Business

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.